Literature DB >> 34510437

Sorting nexin 6 interacts with Cullin3 and regulates programmed death ligand 1 expression.

Chinmoy Ghosh1, Yanli Xing2, Suhua Li1, Rosalie G Hoyle3, Ming Sun1, Jiong Li3,4, Yue Sun1,4.   

Abstract

Programmed death ligand 1 (PD-L1) is critical for the ability of cancer cells to evade attacks by the host immune system. However, the molecular mechanisms controlling PD-L1 expression have not been fully understood. Here, we demonstrate that sorting nexin 6 (SNX6) is a novel regulator of PD-L1 expression. Knockdown of SNX6 in cancer cells significantly decreases PD-L1 protein levels. In contrast, loss of SNX6 does not reduce PD-L1 mRNA levels. Instead, SNX6 interacts with Cullin3, an E3 ubiquitin ligase responsible for PD-L1 ubiquitination and subsequent degradation. By binding with Cullin3, SNX6 decreases the interaction between the adaptor protein speckle-type POZ protein and Cullin3, which in turn downregulates Cullin3-mediated PD-L1 ubiquitination. This research reveals a novel molecular nexus in modulating PD-L1.
© 2021 Federation of European Biochemical Societies.

Entities:  

Keywords:  Cullin3; PD-L1; SNX6; SPOP; immune checkpoint; immunotherapy

Mesh:

Substances:

Year:  2021        PMID: 34510437      PMCID: PMC8545913          DOI: 10.1002/1873-3468.14191

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   3.864


  51 in total

1.  Loss of sorting nexin 5 stabilizes internalized growth factor receptors to promote thyroid cancer progression.

Authors:  Sumito Jitsukawa; Ryuta Kamekura; Koji Kawata; Fumie Ito; Akinori Sato; Hiroshi Matsumiya; Tomonori Nagaya; Keiji Yamashita; Terufumi Kubo; Tomoki Kikuchi; Noriyuki Sato; Tadashi Hasegawa; Hiroshi Kiyonari; Yoshiko Mukumoto; Ken-Ichi Takano; Tetsuo Himi; Shingo Ichimiya
Journal:  J Pathol       Date:  2017-11       Impact factor: 7.996

2.  PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells.

Authors:  P'ng Loke; James P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-15       Impact factor: 11.205

3.  Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.

Authors:  Michael R Green; Stefano Monti; Scott J Rodig; Przemyslaw Juszczynski; Treeve Currie; Evan O'Donnell; Bjoern Chapuy; Kunihiko Takeyama; Donna Neuberg; Todd R Golub; Jeffery L Kutok; Margaret A Shipp
Journal:  Blood       Date:  2010-07-13       Impact factor: 22.113

Review 4.  The Phox (PX) domain proteins and membrane traffic.

Authors:  Li-Fong Seet; Wanjin Hong
Journal:  Biochim Biophys Acta       Date:  2006-05-06

5.  Tumor suppressor p27(Kip1) undergoes endolysosomal degradation through its interaction with sorting nexin 6.

Authors:  José J Fuster; José M González; María D Edo; Rosa Viana; Patricia Boya; Javier Cervera; Marcel Verges; José Rivera; Vicente Andrés
Journal:  FASEB J       Date:  2010-03-12       Impact factor: 5.191

6.  Metastasis suppression by breast cancer metastasis suppressor 1 involves reduction of phosphoinositide signaling in MDA-MB-435 breast carcinoma cells.

Authors:  Daryll B DeWald; Javad Torabinejad; Rajeev S Samant; Derrick Johnston; Nuray Erin; Joseph C Shope; Yi Xie; Danny R Welch
Journal:  Cancer Res       Date:  2005-02-01       Impact factor: 12.701

7.  PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells.

Authors:  Yvette E Latchman; Spencer C Liang; Yin Wu; Tatyana Chernova; Raymond A Sobel; Martina Klemm; Vijay K Kuchroo; Gordon J Freeman; Arlene H Sharpe
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

8.  Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin.

Authors:  Tilman Schneider-Poetsch; Jianhua Ju; Daniel E Eyler; Yongjun Dang; Shridhar Bhat; William C Merrick; Rachel Green; Ben Shen; Jun O Liu
Journal:  Nat Chem Biol       Date:  2010-01-31       Impact factor: 15.040

Review 9.  Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future.

Authors:  Lieping Chen; Xue Han
Journal:  J Clin Invest       Date:  2015-09-01       Impact factor: 14.808

10.  The retromer coat complex coordinates endosomal sorting and dynein-mediated transport, with carrier recognition by the trans-Golgi network.

Authors:  Thomas Wassmer; Naomi Attar; Martin Harterink; Jan R T van Weering; Colin J Traer; Jacqueline Oakley; Bruno Goud; David J Stephens; Paul Verkade; Hendrik C Korswagen; Peter J Cullen
Journal:  Dev Cell       Date:  2009-07       Impact factor: 12.270

View more
  1 in total

1.  CUL3/SPOP complex prevents immune escape and enhances chemotherapy sensitivity of ovarian cancer cells through degradation of PD-L1 protein.

Authors:  Min Dong; Min Qian; Zhengyi Ruan
Journal:  J Immunother Cancer       Date:  2022-10       Impact factor: 12.469

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.